Effectiveness of Aldosterone Blockade in Patients With Diabetic Nephropathy
Top Cited Papers
Open Access
- 1 January 2003
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Hypertension
- Vol. 41 (1), 64-68
- https://doi.org/10.1161/01.hyp.0000044937.95080.e9
Abstract
It has been reported that continuous ACE inhibitor therapy does not necessarily produce a maintained decrease in plasma aldosterone levels, which may remain high or increase eventually during long-...Keywords
This publication has 26 references indexed in Scilit:
- Diabetic NephropathyDiabetes Care, 2002
- Spironolactone in Addition to ACE Inhibition to Reduce Proteinuria in Patients with Chronic Renal DiseaseNew England Journal of Medicine, 2001
- Aldosterone Escape during Angiotensinconverting Enzyme Inhibitor Therapy in Essential Hypertensive Patients with Left Ventricular HypertrophyJournal of International Medical Research, 2001
- Effects of spironolactone on systolic blood pressure in experimental diabetic ratsKidney International, 2000
- The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart FailureNew England Journal of Medicine, 1999
- The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureArchives of Internal Medicine, 1997
- Aldosterone escape during angiotensin-converting enzyme inhibitor therapy in chronic heart failureJournal of Cardiac Failure, 1996
- Use of Single Voided Urine Samples to Estimate Quantitative ProteinuriaNew England Journal of Medicine, 1983
- Increase in plasma aldosterone during prolonged captopril treatmentThe American Journal of Cardiology, 1982
- STIMULATION OF ACTIVE SODIUM TRANSPORT BY THE ISOLATED TOAD BLADDER WITH ALDOSTERONE IN VITRO*Journal of Clinical Investigation, 1961